摘要
目的探讨普米克气雾剂治疗小儿咳嗽变异性哮喘的疗效。方法回顾分析2008年6月至2009年10月儿科49例患儿的临床资料。结果治疗组显效20例,有效3例,无效2例,总有效率92.0%;对照组显效8例,有效7例,无效9例,总有效率65.0%。治疗组总有效率明显高于对照组。结论普米克气雾剂治疗CVA可直接吸入靶细胞,起到强抗炎作用,很少入血或入血后在肝脏灭活。本文两组总有效率及复发率比较均有显著性差异,表明普米克气雾剂吸入治疗小儿咳嗽变异性哮喘具有起效快、疗效确切、复发率低、不良反应小等优点,值得临床推广使用。
Objective To explore the Pulmicort aerosol treatment of children with cough variant asthma（CVA）.Methods Retrospective analysis of our hospital in June 2008 ～ October 2009 pediatric clinical data in children.Results The treatment group 20 cases markedly effective in 5 cases,3 cases,the total effective rate 92.0%;control group,8 cases markedly effective in 7 cases,9 cases no effect,the total effective rate 65.0%.The total effective treatment group was significantly higher,after statistical processing,P0.05 indicates significant effect of treatment group than the control group.Conclusion The Pulmicort Aerosol inhalation treatment of CVA can directly target cells,play a strong anti-inflammatory effects,very few enter into the blood after the blood or inactivated in the liver.The total effective rate and relapse rate of groups were significantly difference,indicating that Pulmicort aerosol inhalation treatment of children with cough variant asthma onset has rapid curative effect,the recurrence rate is low,side effects,etc,should promote the use.
出处
《医药论坛杂志》
2010年第14期51-52,共2页
Journal of Medical Forum
